Identifying potential pharmacological targets and mechanisms of vitamin D for hepatocellular carcinoma and COVID-19
Article
[키워드] ACTA1
aggressiveness
ALB
analyses
Analysis
analyzed
Anti-inflammatory
anti-inflammatory action
Antiviral effect
binding activity
bioinformatics
Biological functions
chemokine
Coronavirus disease 2019
COVID-19
cytokine production
digestive system
Effect
effective
enrichment analysis
epithelial
evaluate
HCC
HCC patient
HCC patients
help
hepatocellular
Hepatocellular carcinoma
HMOX1
identifying
immune response
immunomodulatory
involved
malignancy
mechanism
molecular
molecular docking
molecular mechanism
network pharmacology
pandemic
performed
pharmacological target
poor prognosis
Predictive
Prognosis
prognostic
public health
RBP4
Regulation
risk
Seven
signaling pathway
target gene
Target genes
therapeutic effect
TLR4
TTR
Vitamin D
with COVID-19
[DOI] 10.3389/fimmu.2022.985781 PMC 바로가기
[DOI] 10.3389/fimmu.2022.985781 PMC 바로가기